MediGene

This article does not cite any sources. Please help by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources:  –  ·  ·  · scholar · JSTOR (May 2021) (Learn how and when to remove this template message)

Medigene AG

Type	Stock company
Traded as	MDG1
Industry	Biotechnology
Founded	1994
Headquarters	Martinsried, Germany
Key people	Prof Dolores J Schendel (CEO), Gerd Zettlmeissl (Chairman of the supervisory board)
Website	www.medigene.com

Medigene AG (FSE: MDG1, ISIN DE000A1X3W00, Prime Standard) is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development.

External links[]

• Official website

This German corporation or company article is a stub. You can help Wikipedia by .

• v
• t